Sign in
4

Changes in Ownership

Outlook Therapeutics, Inc. Filed Acc 0001209191-23-021907

Options or other derivatives

  • Director acquired 41,065 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Gangolli Julian S · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-03-29 Grant or award : show line 1 in the form Stock Option (Right to Buy) +41,065 41,065 D
Loading xslF345X04/doc4.xml…